US Patent Issued to Board of Regents, The University of Texas System on Sept. 29 for "Tubulin polymerization inhibitor for cancer therapy" (Texas Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,746,228, issued on Sept. 29, was assigned to Board of Regents, The University of Texas System (Austin, Texas).

"Tubulin polymerization inhibitor for cancer therapy" was invented by Renato J. Aguilera (El Paso, Texas) and Edgar A. Borrego Puerta (El Paso, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is a compound and method for treating cancer cells. The method comprises administering cancer cells with a compound having the chemical structure of 2-{4-[4-methoxy-3-(trifluoromethyl)phenyl]-1H-pyrazol-1-yl}-N-(2-methyl-2H-1,2,3-triazol-4-yl)acetamide to induce apoptosis of the cancer cells and inhibit tubulin polymerization."

The p...